Roche Holding AG

Roche Holding AG's reported carbon emissions

Roche Holding AG, headquartered in CH and operating in the Pharmaceutical Preparation Manufacturing industry, has outlined ambitious climate commitments and reported significant carbon emissions. **Recent Emissions Data:** For the 2025 reporting year, Roche reported a total of approximately 4.52 billion kg CO2e. This figure is comprised of Scope 1 emissions totalling about 211.96 million kg CO2e, Scope 2 emissions at approximately 8.53 million kg CO2e (market-based), and substantial Scope 3 emissions amounting to approximately 4.30 billion kg CO2e. In 2024, total emissions were approximately 4.43 billion kg CO2e, with Scope 1 at 245.83 million kg CO2e, Scope 2 at 69.20 million kg CO2e (market-based), and Scope 3 at approximately 4.11 billion kg CO2e. For 2023, the total emissions were approximately 6.37 billion kg CO2e, consisting of Scope 1 emissions of about 240.27 million kg CO2e, Scope 2 emissions of approximately 98.48 million kg CO2e, and Scope 3 emissions totalling about 6.04 billion kg CO2e. **Climate Commitments and Reduction Targets:** Roche Holding AG is committed to achieving net-zero emissions across its entire value chain by 2045. Supporting this overarching goal, the company has set several near-term and long-term targets: * **Near-Term (by 2029, from a 2022 base year):** * A 70% reduction in absolute Scope 1 greenhouse gas (GHG) emissions. * A 70% reduction in absolute Scope 2 GHG emissions. * A 22.5% reduction in absolute Scope 3 GHG emissions for categories including fuel- and energy-related activities, waste generated in operations, and business travel. * A further 22.5% reduction in absolute Scope 3 GHG emissions related to the use of sold products and their end-of-life treatment. * Commitment that 70% of suppliers, by emissions, covering purchased goods and services, capital goods, and upstream transportation and distribution will have science-based targets by 2029. * **Long-Term (by 2045, from a 2022 base year):** * A 90% reduction in absolute Scope 1 GHG emissions. * A 90% reduction in absolute Scope 2 GHG emissions. * A 90% reduction in absolute Scope 3 GHG emissions. Additionally, Roche had a mid-term goal to reduce consumed energy from Scope 1 and Scope 2 sources per employee by 15% within its own facilities by 2025, starting from a 2015 baseline.